Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.660 | 2.660 | 0.000 |
Stocks | 97.340 | 97.340 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.913 | 29.575 |
Price to Book | 8.287 | 7.066 |
Price to Sales | 5.678 | 5.037 |
Price to Cash Flow | 23.847 | 20.295 |
Dividend Yield | 0.872 | 0.660 |
5 Years Earnings Growth | 11.369 | 15.720 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 37.410 | 12.682 |
Technology | 26.880 | 37.683 |
Financial Services | 18.560 | 10.556 |
Consumer Cyclical | 8.910 | 15.118 |
Communication Services | 4.550 | 12.041 |
Industrials | 3.680 | 7.346 |
Number of long holdings: 24
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Mastercard | US57636Q1040 | 7.59 | 533.11 | -0.21% | |
Microsoft | US5949181045 | 7.24 | 442.95 | -0.84% | |
UnitedHealth | US91324P1021 | 6.12 | 532.13 | +0.45% | |
Tyler Technologies | US9022521051 | 5.72 | 590.84 | -0.44% | |
IDEXX Labs | US45168D1046 | 5.63 | 435.02 | +0.62% | |
West Pharmaceutical Services | US9553061055 | 5.61 | 344.58 | +0.17% | |
Booking | US09857L1089 | 4.55 | 4,756.50 | -1.28% | |
ADP | US0530151036 | 4.44 | 297.05 | +0.42% | |
Alphabet A | US02079K3059 | 4.43 | 199.94 | +0.99% | |
Accenture | IE00B4BNMY34 | 4.42 | 362.37 | -0.25% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seilern Stryx World Growth EUR U | 1.72B | 7.80 | -1.35 | 12.42 | ||
Seilern Stryx World Growth EUR H R | 1.72B | 2.23 | -5.57 | 9.49 | ||
IE00BF5H5052 | 2.01B | 2.88 | -4.96 | - | ||
IE00BD8DY654 | 291.87M | 4.02 | -3.82 | - | ||
IE00B68JD125 | 69.28M | 7.48 | -0.77 | 6.86 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review